Rai, S., Kim, W. S., Ando, K., Choi, I., Izutsu, K., Tsukamoto, N., Maruyama, D., Tsukasaki, K., Kuroda, J., Ando, J., Hidaka, M., Koh, Y., Kato, H., Uchida, T., Yang, D. H., Ishitsuka, K., Ishizawa, K., Kim, J. S., Lee, H. G., Minami, H., Eom, H. S., Kurosawa, M., Lee, J. H., Lee, J. S., Lee, W. S., Nagai, H., Shindo, T., Yoon, D. H., Yoshida, S., Gillings, M., Onogi, H. and Tobinai, K. (2020) “Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.283992.